Cargando…

Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease

OBJECTIVES: The aim of this study was to investigate the effects of compound C on an in vivo mouse model of high-fat diet- (HFD-) induced obesity and hepatosteatosis. METHODS: C57BL/6 mice were fed with a standard diet (n = 5) for 16 weeks and then injected saline once a day for 4 weeks as the norma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Fang, Liu, Yuxing, Yuan, Jingjing, Yang, Wenjun, Mo, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6710782/ https://www.ncbi.nlm.nih.gov/pubmed/31485221 http://dx.doi.org/10.1155/2019/3206587

Ejemplares similares

Nobiletin Intake Attenuates Hepatic Lipid Profiling and Oxidative Stress in HFD-Induced Nonalcoholic-Fatty-Liver-Disease Mice
por: Ke, Zunli, et al.
Publicado: (2023)

Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification
por: Jiang, Hui, et al.
Publicado: (2022)

Leukemia inhibitory factor protects against liver steatosis in nonalcoholic fatty liver disease patients and obese mice
por: Yuan, Youwen, et al.
Publicado: (2022)

Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice
por: Morinaga, Hidetaka, et al.
Publicado: (2015)

Therapeutic efficacy of polydatin for nonalcoholic fatty liver disease via regulating inflammatory response in obese mice
por: Mo, Juan-Fen, et al.
Publicado: (2018)

Effect of vitamin D3 on lipid droplet growth in adipocytes of mice with HFD‐induced obesity
por: Zhang, Jingjing, et al.
Publicado: (2023)

Quantitative proteomics of HFD-induced fatty liver uncovers novel transcription factors of lipid metabolism
por: Zhi, Shang, et al.
Publicado: (2022)

Isoquercetin Improves Hepatic Lipid Accumulation by Activating AMPK Pathway and Suppressing TGF-β Signaling on an HFD-Induced Nonalcoholic Fatty Liver Disease Rat Model
por: Qin, Guohong, et al.
Publicado: (2018)

Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)

Ramulus Mori (Sangzhi) Alkaloids Alleviate High-Fat Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
por: Chen, Yan-Min, et al.
Publicado: (2022)

Data on biochemical indexes of HFD-fed mice treatment with metformin or resveratrol
por: Zhao, Wenjun, et al.
Publicado: (2016)

Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice
por: Tu, Lan N., et al.
Publicado: (2017)

Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity
por: Gentile, Daniela, et al.
Publicado: (2018)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
por: Wang, Xin, et al.
Publicado: (2011)

Zinc-α2-Glycoprotein Is Associated with Obesity in Chinese People and HFD-Induced Obese Mice
por: Liu, Meijuan, et al.
Publicado: (2018)

Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice
por: Jacobs, Sophie A.H., et al.
Publicado: (2019)

Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
por: Cheng, Can, et al.
Publicado: (2019)

LepRb(+) cell–specific deletion of Slug mitigates obesity and nonalcoholic fatty liver disease in mice
por: Kim, Min-Hyun, et al.
Publicado: (2023)

Anti-NAFLD Effect of Djulis Hull and Its Major Compound, Rutin, in Mice with High-Fat Diet (HFD)-Induced Obesity
por: Tung, Yu-Tang, et al.
Publicado: (2021)

Protective Effect of Diet-Supplemented and Endogenously Produced Omega-3 Fatty Acids against HFD-Induced Colon Inflammation in Mice
por: Thomas, Shalom Sara, et al.
Publicado: (2022)

Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity
por: Zhang, Junfeng, et al.
Publicado: (2020)

Protective effect of phytoestrogens on nonalcoholic fatty liver disease in postmenopausal women
por: Zhao, ChenLu, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease in obese and nonobese pediatric patients
por: Kim, Eun Jeong, et al.
Publicado: (2019)

Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice
por: Rom, Oren, et al.
Publicado: (2019)

Effects of Mogrosides on High-Fat-Diet-Induced Obesity and Nonalcoholic Fatty Liver Disease in Mice
por: Zhang, Xiaobing, et al.
Publicado: (2018)

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice
por: Qian, Minyi, et al.
Publicado: (2019)

Risperidone Exacerbates Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Renal Impairment in Obese Mice
por: Tsai, Hsiao-Pei, et al.
Publicado: (2021)

Metformin ameliorates hepatic steatosis and improves the induction of autophagy in HFD-induced obese mice
por: Li, Min, et al.
Publicado: (2017)

Adipocyte PU.1 knockout promotes insulin sensitivity in HFD-fed obese mice
por: Lackey, Denise E., et al.
Publicado: (2019)

Protective effect of celastrol on type 2 diabetes mellitus with nonalcoholic fatty liver disease in mice
por: Sun, JuanJuan, et al.
Publicado: (2020)

Ilex latifolia Thunb protects mice from HFD-induced body weight gain
por: Wu, Hailan, et al.
Publicado: (2017)

Protective Effects of MitoTEMPO on Nonalcoholic Fatty Liver Disease via Regulating Myeloid-Derived Suppressor Cells and Inflammation in Mice
por: Wu, Jiayuan, et al.
Publicado: (2020)

Hepatic transcriptome signatures in mice and humans with nonalcoholic fatty liver disease
por: Ding, Yiming, et al.
Publicado: (2023)

Total Flavonoids from Chimonanthus nitens Oliv. Leaves Ameliorate HFD-Induced NAFLD by Regulating the Gut–Liver Axis in Mice
por: Meng, Wenya, et al.
Publicado: (2022)

Lycium ruthenicum Murr. alleviates nonalcoholic fatty liver in mice
por: Lu, Keke, et al.
Publicado: (2020)

Metabolic and Hepatic Effects of Empagliflozin on Nonalcoholic Fatty Liver Mice
por: Niu, Shu, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals
por: Masuoka, Howard C, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gm896pqfe0bckbesq8t8ciflih